CDH1 and neoplasm: Interestingly, loss of membranous E-cadherin/β-catenin and increased cytoplasmic ALCAM expression was significantly associated in OSCCs and correlated with aggressive tumor behavior (enhanced tumor invasiveness, late clinical stage, and nodal metastasis).